April 30, 2026 Alliance Entertainment to Host Third Quarter Fiscal Year 2026 Results Conference Call on May 14 at 4:30 p.m. Eastern Time
April 30, 2026 Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors
April 30, 2026 Cadrenal Therapeutics Announces End-of-Phase 2 Meeting with the FDA and Pivotal Phase 3 Registration Path for CAD-1005 in Heparin-Induced Thrombocytopenia (HIT)
April 30, 2026 Sprouse Windows & Doors Debuts New Brand and Website, Building on Five Decades of Vinyl Manufacturing in West Virginia
